The FDA says it is ending its emergency use authorization for chloroquine and hydroxychloroquine.
The agency determined the drugs were "unlikely to be effective in treating COVID-19 for the authorized uses in the EUA."
"Additionally, in light of ongoing serious cardiac adverse events and other serious side effects, the known and potential benefits of CQ and HCQ no longer outweigh the known and potential risks for the authorized use," the FDA wrote in its notice Monday. The FDA issued the emergency use authorization for the drugs in March. The EUA meant that doctors would be allowed to use the drugs on patients hospitalized with Covid-19 even though they had not been formally approved by the agency.
However, the agency warned consumers a month later against taking the drugs to treat Covid-19 outside a hospital or formal clinical trial setting due to the risk of "serious heart rhythm problems" in some patients.coronavirusWhite House physician Dr.
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
FDA terminates emergency use authorization of hydroxychloroquine for Covid-19The FDA pulls its emergency use authorization of hydroxychloroquine for Covid-19 treatment, citing the latest scientific evidence
Read more »
FDA Pulls Emergency Covid-19-Use Approval for Two Malaria Drugs Touted by TrumpBreaking: The FDA has revoked its emergency-use authorization for two malaria drugs, chloroquine and hydroxychloroquine, for the treatment of Covid-19. Both were widely touted by President Trump and others as useful in helping coronavirus patients.
Read more »
FDA pulls emergency use authorization of hydroxychloroquine for COVID-19BREAKING: FDA rescinds emergency use authorization for hydroxychloroquine to treat hospitalized COVID-19 patients, saying the drug carries too many risks without any apparent benefit.
Read more »